IXLAB Trademark

Trademark Overview


On Monday, October 14, 2024, a trademark application was filed for IXLAB with the United States Patent and Trademark Office. The USPTO has given the IXLAB trademark a serial number of 79410331. The federal status of this trademark filing is RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Tuesday, July 7, 2026. This trademark is owned by SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO.. The IXLAB trademark is filed in the Computer & Software Products & Electrical & Scientific Products category with the following description:

Recorded computer programs, recorded computer software platforms, downloadable computer software platforms, downloadable computer software applications, downloadable computer programs, and recorded computer software for comprehensive monitoring and management of medical examination and testing processes, namely, remotely monitoring the status of instruments and environmental conditions, visualizing data, and verifying compliance with documentation, processes, and quality metrics; recorded computer programs, recorded computer software platforms, downloadable computer software platforms, downloadable computer software applications, downloadable computer programs, and recorded computer software for pipeline management, namely, collecting, managing, and displaying data from various instruments on a production line; recorded computer programs, recorded computer software platforms, downloadable computer software platforms, downloadable computer software applications, downloadable computer pr...
ixlab

General Information


Serial Number79410331
Word MarkIXLAB
Filing DateMonday, October 14, 2024
Status661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED
Status DateTuesday, July 7, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesRecorded computer programs, recorded computer software platforms, downloadable computer software platforms, downloadable computer software applications, downloadable computer programs, and recorded computer software for comprehensive monitoring and management of medical examination and testing processes, namely, remotely monitoring the status of instruments and environmental conditions, visualizing data, and verifying compliance with documentation, processes, and quality metrics; recorded computer programs, recorded computer software platforms, downloadable computer software platforms, downloadable computer software applications, downloadable computer programs, and recorded computer software for pipeline management, namely, collecting, managing, and displaying data from various instruments on a production line; recorded computer programs, recorded computer software platforms, downloadable computer software platforms, downloadable computer software applications, downloadable computer programs, and recorded computer software for laboratory information management, namely, managing information related to laboratory inventory of products and consumables, documentation, equipment, personnel, samples, and laboratory environment; recorded computer programs, recorded computer software platforms, downloadable computer software platforms, downloadable computer software applications, downloadable computer programs, and recorded computer software for scientific research assistance in the nature of assisting with report interpretation, calculations and graphing, answering research questions, building knowledge graphs, and follow-up tracking; recorded computer programs, recorded computer software platforms, downloadable computer software platforms, downloadable computer software applications, downloadable computer programs, and recorded computer software for disease prediction in the nature of diagnosing diseases, namely, cancer, endocrine and metabolic disorders, cardiovascular and thromboembolic diseases, liver and gastrointestinal diseases, reproductive diseases, neurological diseases, infectious diseases, autoimmune and rheumatic diseases, and kidney diseases, based on blood, bodily fluid, and tissue sample data, and providing diagnostic results; none of the foregoing being software for inhaler, nebulizer, nasal spray, aerosol, or dosage unit testing apparatus.
Pseudo MarkIX LAB
Description of MarkThe mark consists of the stylized word IXLAB where there are two lines with circles at the end extending to the left of the dot above the letter "I" in IXLAB.

Classification Information


International Class009 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments; apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling electricity; apparatus for recording, transmission or reproduction of sound or images; magnetic data carriers, recording discs; automatic vending machines and mechanisms for coin operated apparatus; cash registers, calculating machines, data processing equipment and computers; fire extinguishing apparatus.
US Class Codes021, 023, 026, 036, 038
Class Status Code6 - Active
Class Status DateThursday, November 21, 2024
Primary Code009
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCN

Trademark Events


Event DateEvent Description
Thursday, November 21, 2024SN ASSIGNED FOR SECT 66A APPL FROM IB
Sunday, November 24, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sunday, November 24, 2024APPLICATION FILING RECEIPT MAILED
Sunday, March 23, 2025ASSIGNED TO EXAMINER
Monday, March 24, 2025NON-FINAL ACTION WRITTEN
Tuesday, March 25, 2025NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Friday, May 16, 2025NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
Friday, May 23, 2025NON-FINAL ACTION WRITTEN
Saturday, May 24, 2025NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, July 15, 2025REFUSAL PROCESSED BY MPU
Wednesday, July 16, 2025NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, August 1, 2025REFUSAL PROCESSED BY IB
Monday, November 10, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, November 10, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, November 10, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, January 9, 2026NON-FINAL ACTION WRITTEN
Friday, January 9, 2026NON-FINAL ACTION E-MAILED
Friday, January 9, 2026NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, April 20, 2026NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Monday, April 20, 2026NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Thursday, May 7, 2026NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Wednesday, June 17, 2026TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, June 17, 2026ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, June 17, 2026TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, June 17, 2026TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Tuesday, July 7, 2026TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, July 7, 2026CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, July 7, 2026TEAS/EMAIL CORRESPONDENCE ENTERED